Search PubMed⌕ Search

Biomedical subjects

D Chiu

Publications and source records attributed to D Chiu.

59 records · Page 4Linked to original sources
PubMed1976

Creatine phosphokinase release as a measure of tourniquet effect on skeletal muscle.

In anesthetized dogs, a pneumatic tourniquet was applied to a hind limb for one, two, or three hours. Resultant ischemic damage to skeletal muscle was assessed by creatine phosphokinase (CPK) levels in the femoral venous blood of the experimental limb after the tourniquet was released. The CPK levels did not rise after release of one-hour occlusion in three experiments. The elevation of CPK values was demonstrated after occlusion for two hours in three of four experiments, and after occlusion of three hours in all four experiments. When a three-hour occlusion was interrupted for 15 minutes after each hour in three experiments, elevation of CPK levels was minimal or absent. Thus, skeletal muscle injury, as measured by the level of venous CPK elevation, becomes apparent after two to three hours of occlusion and can be prevented by short periods of recirculation.

Animals↗
PubMedDate not supplied

Sibling HLA-matched cord blood transplant for beta-thalassemia: report of two cases, expression of fetal hemoglobin, and review of the literature.

PURPOSE: A program of cord blood stem cell (CBSC) transplants for patients with beta-thalassemia major was initiated in conjunction with the prenatal diagnostic service in 1994. Two patients who received HLA-matched related CBSC transplants with posttransplant fetal hemoglobin (HbF) expression are described and the literature is reviewed. PATIENTS AND METHODS: After screening 12 pregnancies, matched sibling CBSC transplants were performed for 2 girls with beta-thalassemia major when they were 3.8 and 2.2 years old, respectively. Their HbF was assayed serially. RESULTS: The nucleated cell counts/kg were 11.4 x 10(7) and 6.2 x 10(7), which engrafted on days 19 and 24, respectively. The children are now transfusion-independent at 3 years and 1.2 years posttransplant. Their HbF levels showed a rapid rise posttransplant and reached peak levels of 37.2% and 42.2% on day 83 and day 88, respectively. The HbF levels declined to 1.0% and 3.8% on day 581 and day 305, respectively. Nine other sibling CBSC transplants for thalassemias have been reported with an engraftment rate of approximately 50%. Graft rejection was related to insufficient CBSC number in one. CONCLUSIONS: HbF levels in patients with beta-thalassemia major after CBSC transplants could be influenced by many factors, including reactivation of HbF synthesis, intrinsic rate of Hb switching of CBSC, and mixed chimerism.

Female↗